SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001689375-24-000045
Filing Date
2024-08-13
Accepted
2024-08-13 07:05:42
Documents
15
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K trda-20240813.htm   iXBRL 8-K 29000
2 EX-99.1 a2q24earningsrelease.htm EX-99.1 58952
6 GRAPHIC image_0.jpg GRAPHIC 30141
  Complete submission text file 0001689375-24-000045.txt   269853

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trda-20240813.xsd EX-101.SCH 1907
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trda-20240813_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trda-20240813_pre.xml EX-101.PRE 13585
17 EXTRACTED XBRL INSTANCE DOCUMENT trda-20240813_htm.xml XML 2928
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 241198737
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)